Previous 10 | Next 10 |
The spread of the “recession” meme is starting to reach a fever pitch (1). In this case, it could counterintuitively be a positive catalyst for the long duration side of the market – ie, the long-term growth bets that are still in their early innings, with big fireworks s...
I will offer some perspective about how bad today's market action was and what it may mean going forward. Of the 1,505 stocks in the S&P 1500 Composite index, only 78 were up today, while 1,422 were down and 5 were unchanged. There are now 1,010 stocks (67.1% of the index) tha...
Zynex Medical to Participate in Upcoming Investor Conferences PR Newswire ENGLEWOOD, Colo. , May 10, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasi...
Zynex Ranks 250 in Financial Times List of "The Americas' Fastest Growing Companies 2022" PR Newswire ENGLEWOOD, Colo. , May 3, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) , an innovative medical technology company specializing in the manufac...
Zynex, Inc. (ZYXI) Q1 2022 Earnings Conference Call April 28, 2022 4:15 PM ET Company Participants Louisa Smith – Investor Relations-Gilmartin Group Thomas Sandgaard – Chairman, President and Chief Executive Officer Anna Lucsok – Chief Operating Officer Don Gregg –...
Zynex press release (NASDAQ:ZYXI): Q1 GAAP EPS of $0.03 misses by $0.02. Revenue of $31.08M (+28.8% Y/Y) beats by $0.06M. Adjusted EBITDA increased 897% to $3.1 million Announced Share Buyback Program up to $10M over next 12 months. As of March 31, 2022, the Company had working capital of $59...
Zynex Announces 2022 First Quarter Earnings PR Newswire ENGLEWOOD, Colo. , April 28, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pa...
Zynex, Inc. to Announce First Quarter 2022 Financial Results PR Newswire ENGLEWOOD, Colo. , April 18, 2022 /PRNewswire/ -- April 18, 2022 – Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufactur...
Trending Health Care Stocks To Watch In The Stock Market This Week As talks of a possible recession by the end of the year arise, investors could be thinking of rotating towards more defensive positions. As such, they could consider investing in health care stocks . This comes a...
Zynex (NASDAQ: ZYXI) board approved a $10M share buyback program. The program will commence April 12, 2022, and end April 11, 2023, or when the $10.0 million buyback limit is reached. Zynex CEO Thomas Sandgaard said, "We believe that the current market value of our shares does not accurately ...
News, Short Squeeze, Breakout and More Instantly...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...